A seasoned fund manager with a strong track record across the technology and healthcare sectors, he has successfully led over 30 investments, demonstrating a keen ability to identify high-potential opportunities. His strategic, data-driven approach has facilitated several notable exits, including a prominent acquisition in the biotech space. Active primarily in North America and Europe, he specializes in early to growth-stage funding, emphasizing operator-first initiatives that enhance portfolio value. With a commitment to thematic investing, his expertise has consistently delivered impressive returns in competitive markets.